CASE REPORT
General Surgery
doi: 10.25005/2074-0581-2024-26-2-333-345
CLEAR CELL RENAL CANCER IN RENAL ALLOGRAFT: CASE STUDY AND LITERATURE REVIEW

R.R. AKHTYAMOV1, S.V. FYODOROV2, O.V. PYANKINA1,3, E.D. KHADIEVA1,3

1District Clinical Hospital, Khanty-Mansiysk, Russian Federation
2Bashkir State Medical University, Ufa, Russian Federation
3Khanty-Mansiysk State Medical Academy, Khanty-Mansiysk, Russian Federation

A retrospective analysis of a patient with renal cell carcinoma (RCC) in renal allografts is presented, providing a comprehensive overview of the patient's medical history, the findings from various examinations, and the surgical interventions. The patient had end-stage renal disease due to nephrosclerosis following a kidney allotransplantation in 2008 and subsequently developed chronic allograft nephropathy. Upon examination, a tumor was discovered in the lower pole of the transplanted kidney. As a result of the end-stage renal transplant failure development, the patient underwent radical surgical treatment using advanced image-guided surgical techniques. This case is a compelling example of the critical importance of regular, thorough screenings for patients undergoing immunosuppressive therapy to identify any potential neoplastic processes promptly.

Keywords: Kidney transplantation, kidney carcinoma, renal allograft embolization, transplant nephrectomy.

Download file:

References
  1. Au E, Wong G, Chapman JR. Cancer in kidney transplant recipients. Nat Rev Nephrol. 2018;14(8):508-20. https://doi.org/10.1038/s41581-018-0022-6
  2. Demir M, Barlas İ. Retrospective analysis of patients who develop cancer after renal transplantation: A 12-year experience in a single center. Cumhuriyet Medical Journal. 2022;44(1):28-30. https://doi.org/10.7197/cmj.1093501
  3. Robinson S, Nag A, Peticca B, Prudencio T, Di Carlo A, Karhadkar S. Renal cell carcinoma in end-stage kidney disease and the role of transplantation. Cancers. 2024;16(1):3. https://doi.org/10.3390/cancers16010003
  4. Ogawa Y, Kojima K, Mannami R, Mannami M, Kitajima K, Nishi M, et al. Transplantation of restored kidneys from unrelated donors after resection of renal cell carcinoma: Results from 10 patients. Transplantation Proceedings. 2015;47(6):1711-9. https://doi.org/10.1016/j.transproceed.2015.06.030
  5. Hevia V, Zakri HR, Taylor FC, Bruins HM, Boissier R, Lledo E, et al. Effectiveness and harms of using kidneys with small renal tumors from deceased or living donors as a source of renal transplantation: A systematic review. Eur Urol Focus. 2019;5(3):508-17. https://doi.org/10.1016/j.euf.2018.01.018
  6. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 update. Eur Urol. 2022;82(4):399-410. https://doi.org/10.1016/j. eururo.2022.03.006
  7. Hanna B, White J, Chalasani V, McGinn S, Winter M. Double partial nephrectomy in allograft transplanted kidney. Urol Case Rep. 2020;35:101517. https://doi. org/10.1016/j.eucr.2020.101517
  8. Krisl JC, Doan VP. Chemotherapy and transplantation: The role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients. Am J Transplant. 2017;17(8):1974-91. https://doi. org/10.1111/ajt.14238
  9. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350-5. https://doi.org/10.1126/science.aar4060
  10. Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K. Renal cell carcinoma and kidney transplantation: A narrative review. Transplantation. 2022;106(1):e52-e63. https://doi.org/10.1097/TP.0000000000003762
  11. Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, at al. Trends in the causes of death among kidney transplant recipients in the United States (1996-2014). Am J Nephrol. 2018;48(6):472-81. https://doi. org/10.1159/000495081
  12. D'Arcy ME, Castenson D, Lynch CF, Kahn AR, Morton LM, Shiels MS, at al. Risk of rare cancers among solid organ transplant recipients. J Natl Cancer Inst. 2021;113(2):199-207. https://doi.org/10.1093/jnci/djaa078
  13. Katabathina VS, Menias CO, Tammisetti VS, Lubner М.G. Malignancy after solid organ transplantation: Comprehensive imaging review. Radiographics. 2016;36(5):1390-407. https://doi.org/10.1148/rg.2016150175
  14. Geynisman DM, Maranchie JK, Ball MW, Bratslavsky G, Singer EA. A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer. Urol Oncol. 2021;39(9):548-60. https://doi.org/10.1016/j.urolonc.2021.04.038
  15. Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797. https://doi.org/10.1136/bmj.g4797
  16. Griffith JJ, Amin KA, Waingankar N, Lerner SM, Delaney V, Ames SA, at al. Solid renal masses in transplanted allograft kidneys: A closer look at the epidemiology and management. Am J Transplant. 2017;17(11):2775-81. https://doi. org/10.1111/ajt.14366
  17. Prins FM, Kerkmeijer LGW, Pronk AA, Vonken EPA, Meijer RP, Bex A, at al. Renal cell carcinoma: Alternative nephron-sparing treatment options for small renal masses, a systematic review. J Endourol. 2017;31(10):963-75. https://doi. org/10.1089/end.2017.0382
  18. Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C, et al. Cancer screening recommendations for solid organ transplant recipients: A systematic review of clinical practice guidelines. Am J Transplant. 2017;17(1):103-14. https://doi.org/10.1111/ajt.13978
  19. Alexander MP, Farag YM, Mittal BV, Rennke HG, Tullius SG, Singh AK. De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int. 2009;75(1):111- 4. https://doi.org/10.1038/ki.2008.228
  20. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013;119(12):2300-8. https://doi. org/10.1002/cncr.28043
  21. Medeiros P, Silva RA, Silva MF Jr, Dantas JH Jr, Paiva RTM, Britto CA. Laparoscopic transplant nephrectomy for failed renal allograft. Transplantation. 2018;102:S538. https://doi.org/10.1097/01.tp.0000543387.59159.2f
  22. Nabavizadeh R, Noorali AA, Makhani SS, Hong G, Holzman S, Patil DH, et al. Transplant radical nephrectomy and transplant radical nephroureterectomy for renal cancer: Postoperative and survival outcomes. Ann Transplant. 2020;25:e925865. https://doi.org/10.12659/AOT.925865
  23. Wendler JJ, Friebe B, Baumunk D, Blana A, Franiel T, Ganzer R, et al. Fokale Therapie von kleinen Nierentumoren. Urologe. 2016;55:594-606. https://doi. org/10.1007/s00120-016-0075-8
  24. Yeast C, Riley JM, Holyoak J, Ross G Jr, Weinstein S, Wakefield M. Use of preoperative embolization prior to Transplant nephrectomy. Int Braz J Urol. 2016;42(1):107-12. https://doi.org/10.1590/S1677-5538.IBJU.2015.0052
  25. Serkies K, Dębska-Ślizień A, Kowalczyk A, Lizakowski S, Małyszko J. Malignancies in adult kidney transplant candidates and recipients: Current status. Nephrol Dial Transplant. 2023;38(7):1591-602. https://doi.org/10.1093/ndt/gfac239

Authors' information:

Akhtyamov Rustem Rashitovich,
Head of the Surgical Department № 3, District Clinical Hospital
ORCID ID: 0009-0003-1867-437X
SPIN: 4644-1746
Author ID: 1227830
Е-mail: ahtyamovrr@okbhmao.ru

Fyodorov Sergey Vladimirovich,
Doctor of Medical Sciences, Professor of the Department of Surgery with Endoscopy Course, Institute of Additional Professional Education, Bashkir State Medical University
Researcher ID: K-5304-2017
ORCID ID: 0000-0002-6106-0301
Author ID: 697647
Е-mail: fedorow707@mail.ru

Pyankina Oksana Vladimirovna,
Candidate of Medical Sciences, Associate Professor of the Department of Hospital Therapy, Khanty-Mansiysk State Medical Academy; Head of the Nephrology Department, District Clinical Hospital
ORCID ID: 0009-0006-2288-024Х
E-mail: pyankinaov@okbhmao.ru

Khadieva Elena Dmitrievna,
Candidate of Medical Sciences, Associate Professor of the Department of Pathological Anatomy, Khanty-Mansiysk State Medical Academy; Head of the Pathological Department, District Clinical Hospital
ORCID ID: 0000-0002-8717-0162
E-mail: hadievaed@okbhmao.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Akhtyamov Rustem Rashitovich
Head of the Surgical Department № 3, District Clinical Hospital

628011, Russian Federation, Khanty-Mansiysk, Kalinin str., 40

Tel.: +7 (903) 3518887

E-mail: ahtyamovrr@okbhmao.ru

Materials on the topic:
  1. PREDICTION OF PERSISTENT PERITONITIS IN THE POSTOPERATIVE PERIOD
  2. REASONS FOR UNSATISFACTORY TREATMENT RESULTS OF ACUTE PURULENT DESTRUCTIVE LUNG DISEASES IN PATIENTS WITH SARS-COV-2 INFECTION
  3. MODERN ASPECTS OF NONPARASITIC LIVER CYSTS
  4. ENDOSCOPIC DIAGNOSTICS AND TREATMENT OF INTRABILIARY RUPTURE OF LIVER HYDATID CYST
  5. SURGICAL WOUND SUPPURATIVE COMPLICATIONS AFTER TENSION-FREE HERNIOPLASTY
  6. THE ROLE OF ENDOTHELIAL DYSFUNCTION IN THE PATHOGENESIS OF LIVER FAILURE IN OBSTRUCTIVE JAUNDICE OF BENIGN ORIGIN
  7. SURGICAL TREATMENT OF INGUINAL HERNIA COMBINED WITH CRYPTORCHIDISM
  8. CLINICAL AND MORPHOLOGICAL EVIDENCE OF THE EFFECTIVENESS OF HYDROGEN PEROXIDE (PERHYDROL) APPLICATION FOR THE RECURRENCE PREVENTION AFTER HYDATID CYSTECTOMY FOR HEPATIC ECHINOCOCCOSIS
  9. CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH UNCOMPLICATED LIVER ECHINOCOCCOSIS
  10. SURGICAL TREATMENT STRATEGIES FOR GIANT ANTERIOR ABDOMINAL WALL HERNIAS

◄ Back to the list